The product production chain of traditional Chinese medicine suffers from low product quality, low efficiency transformation, and insufficient innovation capability, and there lacks complete innovation process chain to address product-independent R&D innovation. For the process chain of Chinese medicine product development, this paper analyzes and discusses the application of Chinese medicine product innovation methods by combining five methods: quality function development (QFD), inventive problem solving theory Teoriya Resheniya Izobreatatelskikh Zadatch (TRIZ), quality by design (QbD), design of experiments (DOE), and data envelopment analysis (DEA). Firstly, QFD is applied to determine the direction of innovation by comprehensive analysis of user needs and actual situation; secondly, TRIZ is applied to analyze and solve the contradictions to be solved by the product, propose solutions and combine QbD and DOE for experimental design and verification; finally, DEA is applied to allocate resources to optimize the efficiency. Combining innovation methods to develop and design Chinese medicine products can develop core technologies and equipment with independent intellectual property rights, effectively improve the quality and effectiveness of Chinese medicine products transformation, which is meaningful for the development of Chinese medicine products.
| 科 Family | 属数 Number of genus | 种数 Number of species | 占总种数比例 Percentage of total species (%) | 属 Genus | 种数 Number of species | 占总种数比例 Percentage of total species (%) |
|---|---|---|---|---|---|---|
| 鹅膏菌科Amanitaceae | 2 | 11 | 5.26 | 鹅膏菌属 Amanita | 10 | 4.78 |
| 小菇科 Mycenaceae | 2 | 12 | 5.74 | 丝盖伞属 Inocybe | 5 | 2.39 |
| 多孔菌科 Polyporaceae | 8 | 14 | 6.70 | 蜡蘑属 Laccaria | 5 | 2.39 |
| 红菇科 Russulaceae | 3 | 23 | 11.00 | 小皮伞属 Marasmius | 6 | 2.87 |
| 小菇属 Mycena | 11 | 5.26 | ||||
| 光柄菇属 Pluteus | 5 | 2.39 | ||||
| 红菇属 Russula | 17 | 8.13 | ||||
| 栓菌属 Trametes | 5 | 2.39 |